What is ICU Medical, Inc. Annual Revenue?

ICU Medical, Inc. Annual Revenue rose 5.44%, in the last year to $2,382.05 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

What is ICU Medical, Inc. Annual Net Profit?

ICU Medical, Inc. Annual Net Profit fell 296.86% in the last year to $117.69 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

What is ICU Medical, Inc. Price to Earning Ratio?

ICU Medical, Inc. Price to Earning Ratio is -28.11, which is negative.

What is ICU Medical, Inc. Stock Price?

ICU Medical, Inc. Stock Price rose 40.36% and outperformed its sector by 34.99% in the past year.

What is ICU Medical, Inc. Quarterly Revenue?

ICU Medical, Inc. Quarterly Revenue rose 7.14% YoY to $629.8 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

What is ICU Medical, Inc. Quarterly Net profit?

ICU Medical, Inc. Quarterly Net profit fell 38.96% YoY to $23.83 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

What is ICU Medical, Inc. Debt to Equity Ratio?

ICU Medical, Inc. Debt to Equity Ratio of 0.84 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is ICU Medical, Inc. Return on Equity(ROE)?

ICU Medical, Inc. Return on Equity(ROE) for the last financial year was -5.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is ICU Medical, Inc. Mutual Fund Holding?

ICU Medical, Inc. Mutual Fund Holding increased by 3.29% in the last quarter to 122.24.

What is ICU Medical, Inc. Promoter Share Holding?

ICU Medical, Inc. Promoter Share Holding increased by 0.09% in the most recent quarter to 0.91%.

What is ICU Medical, Inc. Interest Coverage Ratio?

ICU Medical, Inc. Interest Coverage Ratio is 0.38, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is ICU Medical, Inc. Institutional Holding?

ICU Medical, Inc. Institutional Holding increased by 0.39% in the last quarter to 99.36.

How is the ICU Medical, Inc. today?

The ICU Medical, Inc. today is trading in the down by -3.06% at 134.42.

How has ICU Medical, Inc. performed historically?

The ICU Medical, Inc. is currently trading down -3.06% on an intraday basis in the past week the index fell -5.77%. The index has been down -17.97% in the past quarter and rose 40.36% in the past year. You can view this in the overview section.

ICU Medical, Inc. XNAS: ICUI

ICU Medical, Inc. Live Share Price Today, Share Analysis and Chart

Name: ICU Medical, Inc.: Is Infosys Ltd. worth buying?
Item: ICU Medical, Inc.
Rating: 2.108333375
Author: Trendlyne DVM scores

Mid-range Performer

Download real time

134.42 -4.25 (-3.06%)

31.51% Fall from 52W High

51,576 XNAS Volume

XNAS 21 Apr, 2025 11:55 AM (EDT)

ICU Medical, Inc. Key Metrics

My Metrics

Select

Market Capitalization Below industry Median Unavailable in chosen country	3,308.1
PE TTM Negative PE TTM Unavailable in chosen country	-28.1
PEG TTM Below industry Median Unavailable in chosen country	0.1
Price to Book Below industry Median Unavailable in chosen country	1.7
Institutional holding current Qtr % High in industry Unavailable in chosen country	99.4
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	7.1
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	5.4
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-39
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-296.9
Operating Profit Margin Qtr % Below industry Median Unavailable in chosen country	7.3
Operating Profit Margin TTM % Below industry Median Unavailable in chosen country	4.1
Piotroski Score Below industry Median Unavailable in chosen country	5
Rel Perf vs Sector quarter% Unavailable in chosen country	-9
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-5.8
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-2.7

All financials are in USD Million and price data in USD

Medium Financial Strength

50.0 / 100

Mid Valuation

30.2 / 100

Technically Neutral

38.5 / 100

Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

190

1Yr Price target upside is 41%

5 analysts

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

ICU Medical, Inc. Stock Price Analysis

Day Price Range -3.1% 1 Day return Unavailable in chosen country	134.4 (LTP) 134137.6 LowHigh
Week Price Range -5.8% 1 Week return Unavailable in chosen country	134.4 (LTP) 134145.8 LowHigh
Month Price Range -9.2% 1 Month return Unavailable in chosen country	134.4 (LTP) 130.1152.4 LowHigh
52 Week Price Range 40.4% 1 Year return Unavailable in chosen country	134.4 (LTP) 93.4196.3 LowHigh

View full Share Price History

ICU Medical, Inc. Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

ICU Medical, Inc.'s Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-4.8

Avg. Estimate

-1

Low Estimate

-1.5

High Estimate

-0.2

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 79.5% in FY25

Consensus Recommendation

6 ANALYST Recommendations

BUY

The consensus recommendation from 6 analysts for ICU Medical, Inc. is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

ICU Medical, Inc. Stock Analysis

ICU Medical, Inc. stock analysis with key metrics, changes, and trends.

ICU Medical, Inc. Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$2,382.05 M	5.44%	positive	Annual Revenue rose 5.44%, in the last year to $2,382.05 M. Its sector's average revenue growth for the last fiscal year was 8.57%.
Annual Net Profit	$117.69 M	296.86%	negative	Annual Net Profit fell 296.86% in the last year to $117.69 M. Its sector's average net profit growth for the last fiscal year was 4.36%.
Price to Earning Ratio	-28.11	-	negative	Price to Earning Ratio is -28.11, which is negative.
Stock Price	$134.42	40.36%	positive	Stock Price rose 40.36% and outperformed its sector by 34.99% in the past year.
Quarterly Revenue	$629.8 M	7.14%	positive	Quarterly Revenue rose 7.14% YoY to $629.8 M. Its sector's average revenue growth YoY for the quarter was 8.5%.
Quarterly Net profit	$23.83 M	38.96%	negative	Quarterly Net profit fell 38.96% YoY to $23.83 M. Its sector's average net profit growth YoY for the quarter was 32.89%.
Debt to Equity Ratio	0.84	-	positive	Debt to Equity Ratio of 0.84 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-5.76 %	-5.76%	negative	Return on Equity(ROE) for the last financial year was -5.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	122.24 %	3.29%	positive	Mutual Fund Holding increased by 3.29% in the last quarter to 122.24.
Promoter Share Holding	0.91 %	0.09%	positive	Promoter Share Holding increased by 0.09% in the most recent quarter to 0.91%.
Interest Coverage Ratio	0.38	-	negative	Interest Coverage Ratio is 0.38, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	99.36 %	0.39%	positive	Institutional Holding increased by 0.39% in the last quarter to 99.36.

VIEW LESS

Loading data..

ICU Medical, Inc. - Company Profile

What does ICU Medical, Inc. do?

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

255.02 K

2024

Gross Remuneration

Year

ICU Medical, Inc. Live Share Price Today, Share Analysis and Chart

31.51% Fall from 52W High

ICU Medical, Inc. Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

ICU Medical, Inc. Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

ICU Medical, Inc. Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

ICU Medical, Inc.'s Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to grow by 79.5% in FY25

Consensus Recommendation

The consensus recommendation from 6 analysts for ICU Medical, Inc. is BUY

ICU Medical, Inc. Stock Analysis

ICU Medical, Inc. stock analysis with key metrics, changes, and trends.

Annual Revenue rose 5.44%, in the last year to $2,382.05 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit fell 296.86% in the last year to $117.69 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio is -28.11, which is negative.

Stock Price rose 40.36% and outperformed its sector by 34.99% in the past year.

Quarterly Revenue rose 7.14% YoY to $629.8 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit fell 38.96% YoY to $23.83 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

Debt to Equity Ratio of 0.84 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -5.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 3.29% in the last quarter to 122.24.

Promoter Share Holding increased by 0.09% in the most recent quarter to 0.91%.

Interest Coverage Ratio is 0.38, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding increased by 0.39% in the last quarter to 99.36.

ICU Medical, Inc. - Company Profile

What does ICU Medical, Inc. do?

ICU Medical, Inc. Management structure

Mr. Vivek Jain

Chief Executive Officer and Chairman of the Board

Mr. Christian B. Voigtlander

Chief Operating Officer

Mr. Brian Bonnell

Chief Financial Officer, Principal Accounting Officer and Treasurer

Ms. Virginia Ruth Sanzone

Corporate Vice President, General Counsel and Secretary

Mr. Daniel Woolson

President

ICU Medical, Inc. Board of directors

Mr. David C. Greenberg

Lead Independent Director

Mr. David F. Hoffmeister